Literature DB >> 26781722

Increasing the impact of teleophthalmology in Australia: Analysis of structural and economic drivers in a state service.

Hessom Razavi1, Stephen Paul Copeland1, Angus Warwick Turner1.   

Abstract

PROBLEM: Despite its potential to improve service provision for country patients, teleophthalmology is currently underused in Australia. There is an associated lack of cost-effectiveness data for teleophthamology.
DESIGN: Retrospective and prospective hospital-based clinical audits of 5456 patients; descriptive survey of available telehealth equipment in 129 regional facilities; cost calculations for teleophthalmology, patient transfers and outreach services.
SETTING: Primary (optometry, general practice [GP], Aboriginal Medical Service [AMS]) and secondary (hospital) sites in regional Western Australia; a tertiary hospital in Perth. KEY MEASURES FOR IMPROVEMENT: Proportion of patients suitable for teleophthalmology; proportion of regional practices with telehealth technology; capital expenditure to equip regional practices for teleophthalmology; total savings from increased utilisation of teleophthalmology. STRATEGIES FOR CHANGE: Advocacy for funding, regulatory, training and infrastructure recommendations, in order to support efficient models of teleophthalmology. EFFECTS OF CHANGE: A total of 15% and 24% of urgent patient transfers and outreach consultations, respectively, were found to be suitable for teleophthalmology, equating to a potential total cost saving of $1.1 million/year. Capital expenditure required for basic telehealth equipment was negligible for optometrists, compared to $20 500 per GP/AMS practice. Successful advocacy led to funding, training and policy changes to support optometry-led teleophthalmology for country patients in Australia. LESSONS LEARNT: Public-private partnerships can result in significant cost-savings for the Australian health system. Targeted, evidence-based advocacy can inform government health reforms.
© 2016 National Rural Health Alliance Inc.

Entities:  

Keywords:  Indigenous health; health service evaluation; ophthalmology; rural health; telemedicine

Mesh:

Year:  2016        PMID: 26781722     DOI: 10.1111/ajr.12277

Source DB:  PubMed          Journal:  Aust J Rural Health        ISSN: 1038-5282            Impact factor:   1.662


  6 in total

1.  App-Based Tele Ophthalmology: A Novel Method of Rural Eye Care Delivery Connecting Tertiary Eye Care Center and Vision Centers in India.

Authors:  Anthony Vipin Das; Shravani Mididoddi; Priyanka Kammari; Navya Deepthi Davara; Abhinav Loomba; Rohit Khanna; Mukesh Taneja
Journal:  Int J Telemed Appl       Date:  2019-12-18

2.  Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia.

Authors:  Belinda K Ford; Blake Angell; Gerald Liew; Andrew J R White; Lisa J Keay
Journal:  Int J Integr Care       Date:  2019-11-06       Impact factor: 5.120

3.  Benefits of Integrating Telemedicine and Artificial Intelligence Into Outreach Eye Care: Stepwise Approach and Future Directions.

Authors:  Mark A Chia; Angus W Turner
Journal:  Front Med (Lausanne)       Date:  2022-03-11

Review 4.  Considerations for Training and Workforce Development to Enhance Rural and Remote Ophthalmology Practise in Australia: A Scoping Review.

Authors:  Kehinde Obamiro; Belinda Jessup; Penny Allen; Victoria Baker-Smith; Santosh Khanal; Tony Barnett
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

5.  Use of a Tablet Attachment in Teleophthalmology for Real-Time Video Transmission from Rural Vision Centers in a Three-Tier Eye Care Network in India: eyeSmart Cyclops.

Authors:  Abhinav Loomba; Sandeep Vempati; NavyaDeepthi Davara; M Shravani; Priyanka Kammari; Mukesh Taneja; Anthony Vipin Das
Journal:  Int J Telemed Appl       Date:  2019-04-01

6.  Evaluating the cost and wait-times of a task-sharing model of care for diabetic eye care: a case study from Australia.

Authors:  Nina Tahhan; Belinda Kate Ford; Blake Angell; Gerald Liew; Joseph Nazarian; Glen Maberly; Paul Mitchell; Andrew J R White; Lisa Keay
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.